Barclays Reiterates an 'Overweight' on Bed Bath & Beyond (BBBY); Positive On The Store-In-Store Concept

Barclays reiterates an 'Overweight' on Bed Bath & Beyond (NASDAQ: BBBY) price target of $76.00.

Analyst, Alan M. Rifkin, said, "We recently toured Bed Bath & Beyond's East Hanover, NJ store, which features a broad assortment of higher-end epicurean food and beverages. World Market, as it is named, is an approximate 4,000 square foot department within a traditional Bed Beth & Beyond store, that approximates 50,000 square feet overall."

Rifkin sees continued market share gains with the new store-in-store concept, along with an attractive valuation, despite the growth in e-commerce transactions/competition (Barclays maintains FY12/13 EPS estimate at $0.01/0.07).

For an analyst ratings summary and ratings history on Bed Bath & Beyond click here. For more ratings news on Bed Bath & Beyond click here.

Shares of Bed Bath & Beyond closed at $68.12 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'
• Jefferies on Five Below (FIVE): 'Our latest channel checks reinforce our view that FIVE's momentum extends well beyond viral Squish trends'
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery